
Cliantha Research, a globally recognized full-service Clinical Research Organization (CRO) headquartered in Ahmedabad, has officially opened recruitment for several specialized roles. As an organization that operates under the motto “Science with Integrity,” Cliantha is seeking dedicated professionals to join its clinical and compliance teams.
With over 15 years of successful regulatory history involving major international bodies such as the USFDA, WHO, MHRA, and Health Canada, Cliantha offers a high-standard professional environment for candidates looking to advance their careers in the CRO industry.
Detailed Job Vacancies and Requirements
The current hiring drive covers a broad spectrum of expertise, from entry-level roles to senior compliance auditing.
1. Quality & Compliance Roles
- QA Auditor (Lab): Requires 2 to 4 years of experience. Candidates should hold a B.Pharm, M.Pharm, or M.Sc.
- Global Compliance Cell Auditor: A senior-level role requiring 8 to 10 years of experience specifically in Good Clinical Practice (GCP). Open to B.Pharm, M.Pharm, or M.Sc graduates.
2. Scientific & Medical Roles
- Medical Monitor: This position is open to Freshers with an MBBS + MD in Pharmacology.
- Report Writer (Biometrics): Suitable for M.Sc graduates with 0 to 2 years of experience.
- Trainer: Focused on organizational development, requiring 2 to 4 years of experience and an M.Pharm or M.Sc degree.
3. Business & Strategy Roles
- Business Development (Consumer Research): Requires 2 to 3 years of experience. Open to B.Pharm, M.Pharm, or Pharm.D holders.
- Proposal Developer (Late Phase): Requires 2 to 3 years of experience. Open to B.Pharm, M.Pharm, or Pharm.D holders.
Application Process
Candidates are advised to submit their CVs to the specific HR contact associated with their desired role:
- For Lab QA, Training, Compliance, and Biometrics: 📩 Send CV to: vdesai@cliantha.com
- For Medical Monitor, Business Development, and Proposal Development: 📩 Send CV to: mjunnarkar@cliantha.com
Work Location: Ahmedabad Application Deadline: April 30, 2026
